Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Myxomatous Mitral Valve Disease Receiving Pimobendan or Benazepril: The QUEST Study

Häggström, Jens; Boswood, A.; O'Grady, Michael; Jöns, O.; Smith, S.; Swift, S.; Borgarelli, Michele; Gavaghan, Brad; Kvart, Clarence; DiFruscia, Rocky

doi:10.1111/jvim.12181

Forskningsartikel2013Vetenskapligt granskadÖppen tillgång

Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Myxomatous Mitral Valve Disease Receiving Pimobendan or Benazepril: The QUEST Study

Häggström, Jens; Boswood, A.; O'Grady, Michael; Jöns, O.; Smith, S.; Swift, S.; Borgarelli, Michele; Gavaghan, Brad; Kvart, Clarence; DiFruscia, Rocky

Sammanfattning

Conclusions and Clinical ImportancePimobendan versus benazepril resulted in similar QoL during the study, but conferred increased time before intensification of CHF treatment. Pimobendan treatment resulted in smaller heart size, higher body temperature, and less retention of free water.

Nyckelord

Canine; Mitral regurgitation; Mortality; Therapy

Publicerad i

Journal of Veterinary Internal Medicine
2013, volym: 27, nummer: 6, sidor: 1441-1451
Utgivare: WILEY-BLACKWELL

SLU författare

Häggström, Jens
- Institutionen för kliniska vetenskaper, Sveriges lantbruksuniversitet
Kvart, Clarence
- Institutionen för husdjurens biovetenskaper, Sveriges lantbruksuniversitet

UKÄ forskningsämne

Annan veterinärmedicin

Publikationens identifierare

DOI: https://doi.org/10.1111/jvim.12181

Permanent länk till denna sida (URI)

https://res.slu.se/id/publ/51698